MP35-05 SAFETY AND EFFECTIVENESS OF MAGNETIC URETERAL STENT REMOVAL UNDER ULTRASOUND CONTROL: A RANDOMIZED SINGLE CENTER TRIAL

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP35-05 SAFETY AND EFFECTIVENESS OF MAGNETIC URETERAL STENT REMOVAL UNDER ULTRASOUND CONTROL: A RANDOMIZED SINGLE CENTER TRIAL Nariman Gadjiev, Shkarupa Dmitriy, Obidnyak Vladimir, Gorelov Dmitriy, Semeniakin Igor, Ee Jean Lim, and Vineet Gauhar Nariman GadjievNariman Gadjiev More articles by this author , Shkarupa DmitriyShkarupa Dmitriy More articles by this author , Obidnyak VladimirObidnyak Vladimir More articles by this author , Gorelov DmitriyGorelov Dmitriy More articles by this author , Semeniakin IgorSemeniakin Igor More articles by this author , Ee Jean LimEe Jean Lim More articles by this author , and Vineet GauharVineet Gauhar More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003269.05AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To conduct a study focused on the assessment of the safety and effectiveness of magnetic ureteral stent removal with a special magnet retriever under ultrasound control. METHODS: From October 2020 to March 2022, 60 male patients after semirigid or flexible ureteroscopy were prospectively enrolled and randomly assigned into two groups. Patients in Group A underwent stenting using the conventional double-J ureteric stents and removal with a flexible cystoscope. Group B consisted of patients who underwent stenting using the double-J stent with a cylindrical magnet at its bladder end (Blackstar, Urotech, GmbH). Removal was performed in an outpatient office setting without cystoscopic guidance aided by just a special magnet retriever provided with the stent and under ultrasound guidance. The stent indwelling time lasted for 30 days, during which each patient underwent a follow-up assessment at 3 and 30 days after stent insertion with USSQ and VAS questionnaire immediately after stent removal. RESULTS: A comparison of the USSQ domains revealed no statistically significant differences between the domains of “Urinary symptoms” and “Sexual matters” components. Statistically domains of “Body pain”, “General health score”, “Additional problems”, and “Work performance” favoured regular stents but the differences between the two groups were marginal. Stent removal time was significantly shorter and there was a significantly lower VAS score during stent removal in group B compared to the control group. CONCLUSIONS: Ultrasound-aided, cystoscopy-free, magnet-assisted stent removal is safe, fast, and efficacious and can be done in an outpatient setting. Such an approach obliviates the need for cystoscopy, saves cost and minimizes patient discomfort making this an attractive alternative to traditional stent removal. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e469 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nariman Gadjiev More articles by this author Shkarupa Dmitriy More articles by this author Obidnyak Vladimir More articles by this author Gorelov Dmitriy More articles by this author Semeniakin Igor More articles by this author Ee Jean Lim More articles by this author Vineet Gauhar More articles by this author Expand All Advertisement PDF downloadLoading ...